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ABSTRACT
Objectives: In 2007, the International Agency for
Research on Cancer classiﬁed long-term shift work as
a probable carcinogen, with the strongest evidence for
breast cancer. One proposed mechanism involves
night-time light exposure and decreases in melatonin,
a circadian rhythmic hormone. It is hypothesised that
melatonin inﬂuences patterns of sex hormone
production that in turn inﬂuence breast cancer risk.
This study sought to investigate the relationships of
shift work history, 6-sulfatoxymelatonin (aMTs-6, the
primary melatonin metabolite) and sex hormone levels
among shift working nurses.
Design: This is a cross-sectional biomarker study.
Setting: 94 premenopausal nurses who work
a full-time rotating shift schedule at one Ontario
hospital were recruited for this study; 82 completed
follow-up.
Primary and secondary outcome
measures: Study participants provided morning void
urine and fasting blood samples for the assessment of
aMTs-6 and sex hormone (oestradiol, oestrone,
progesterone, prolactin) levels, respectively. These
data were collected at two time points (summer and
winter) such that relationships between melatonin and
sex hormones could be assessed with respect to two
time frames of interest (acute and cross-seasonal).
Results: An inverse relationship between aMTs-6 and
oestradiol was suggested in the winter (b¼ 0.18,
p¼0.04), but this result was not statistically signiﬁcant
in multivariate modelling that adjusted for age, body
mass index and menstrual cycle. Likewise, while
oestradiol, oestrone and progesterone levels increased
with greater years of shift work history (all p<0.05),
these associations were attenuated after confounder
adjustment.
Conclusions: These results do not support the
proposed relationship between melatonin and sex
hormone levels as biomarkers on the pathway of shift
work and breast cancer but emphasise the importance
of adjusting for confounders in modelling.
INTRODUCTION
As shift work has become essential to our
modern 24-h society, researchers and work-
place compensation boards are increasingly
concerned of possible health effects.
1 The
aetiological role of this prevalent occupa-
tional exposure has been investigated in
numerous health conditions from sleep
disturbances and social well-being to major
chronic diseases, such as heart disease,
metabolic syndrome and cancer.
23Based on
an accumulation of epidemiological and
experimental evidence, shift work was
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ARTICLE SUMMARY
Article focus
- Melatonin and sex hormones are proposed
intermediates in the pathway of shift work to
a possible increased breast cancer risk.
- This hypothesis is based on associations
between shift work, exposure to light at night
and reduced melatonin levels; between reduced
melatonin and increased sex hormone levels and
between increased sex hormone levels and
increased breast cancer risk.
- Few studies have investigated relationships
between melatonin and sex hormone levels in
an observational setting, which is of relevance to
pathways to carcinogenesis, and many studies
are limited by uncontrolled confounding.
Key messages
- The results of this study do not support
hypothesised relationships between shift work,
melatonin and sex hormone levels as intermedi-
ates in the pathway to breast cancer but highlight
the importance of confounder adjustments,
which has not been adequately addressed in
much previous work.
Strengths and limitations of this study
- This study was restricted to women who work
one rotating shift work pattern, which may not be
sufﬁciently disruptive to circadian rhythms to
cause measureable changes in melatonin and/or
sex hormone levels.
- While this may contribute to the lack of
associations observed, it may suggest very
good news to women working this prevalent
rotating shift pattern.
- The study was limited by a small sample size and
was not sufﬁciently powered to detect small
(<0.2) associations between melatonin and sex
hormones.
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Open Access Researchformally classiﬁed as a probable carcinogen by the
International Agency for Research on Cancer in 2007,
with the strongest support provided for breast cancer.
4
While meta-analyses have suggested that shift working
women may be at 40%e50% increased risk of breast
cancer
56 ; individual studies are inconsistent in their
ﬁndings and hence the evidence for this association is
still limited.
7 While future research of cancer risk among
shift workers is necessary, biomarker studies that
investigate possible intermediates of this proposed
relationship are desired to help clarify the plausibility of
this link.
8
One hypothesis for the association between shift work
and breast cancer involves exposure to light at night and
subsequent disturbances to the body’s normal circadian
(24-h) rhythms.
1 67This is highly plausible given that
melatonin, a hormone whose secretion by the pineal
gland is stimulated by darkness and inhibited by light
exposure, has demonstrated cancer-protective effects.
9
In line with most known breast cancer risk factors,
melatonin may interact with sex hormone levels that in
turn regulate the development and progression of breast
tumours.
10e12 In sum, it is postulated that exposure to
light at night during shift work suppresses melatonin
production leading to increases in sex hormones, which
may in turn increase breast cancer risk.
Relationships between melatonin and sex hormone
levels are well known in seasonally breeding animals
whose melatonin secretion, inﬂuenced by seasonal
daylight patterns, controls seasonal mating through
alterations in oestrogen levels.
13 In humans, relationships
between melatonin and sex hormones have been
identiﬁed at menarche and menopause and in certain
pathological conditions, such as anovulation and oopho-
rectomy.
14 In addition, signiﬁcant reductions in sex
hormone levels have been demonstrated in randomised
controlled trials of melatonin supplementation.
15e18
Despite these ﬁndings, there are very limited and incon-
sistent research ﬁndings to indicate the presence of
relationships between melatonin and sex hormones in
healthy women under a normal physiological setting,
which are relevant to pathways in carcinogenesis.
18e22
The purpose of this study was to examine the association
between melatonin, sex hormone levels and shift
work history among healthy premenopausal nurses, as
potential intermediates in the pathway to breast cancer.
MATERIALS AND METHODS
Study population
Following institutional research ethics board approval,
94 cancer-free premenopausal nurses at Kingston
General Hospital (KGH) consented to participate in this
cross-sectional biomarker study. Recruitment took place
from April 2008 to February 2009 through posters and
pamphlets that were sent to all full-time nurses at the
hospital. Women self-excluded if they did not perform
shift work (which is a rotating pattern of two 12-h day
shifts, followed by two 12-h night shifts, followed by
5 days off at this hospital), if they had been pregnant or
lactating in the previous 6 months or if they used mela-
tonin supplements. Of the 94 participants recruited,
seven withdrew from the study and ﬁve did not provide
blood samples and so were excluded. Eighty-two women
(87%) comprised the ﬁnal study sample.
Data collection
Upon study enrolment, participants completed a ques-
tionnaire to gather health, lifestyle and employment
information. Prior to commencing a day shift of their
regular rotating shift pattern (05:00e07:00), nurses
provided morning void urine and fasting blood samples.
At this time, nurses completed a diary to record their
current menstrual cycle stage (follicular (days 0e10),
mid-cycle (days 11e16) and luteal (day 17+), based on
cyclical changes in oestrogen and progesterone levels
over the cycle), current oral contraceptive use, typical
physical activity levels of the past month and daily
caffeine consumption.
These data collection were completed at two time
points, in summer and winter, to investigate two
hypothesised time frames of interest for associations of
melatonin and sex hormone levels, namely (1): imme-
diate (acute) relationships and (2) latent relationships
across seasons. This latter analysis was conducted based
on a hypothesised latency period for inﬂuences of
altered melatonin levels on sex hormones, as demon-
strated from melatonin trials that show signiﬁcant
reductions in sex hormone levels after 4e6 months of
supplementation.
15 16 18 Sixty-eight of the 82 nurses
enrolled participated in the summer study period and 65
in winter, with 51 women completing both study periods
and 31 participating once.
Melatonin assessment
Melatonin levels were characterised by concentrations of
the primary urinary melatonin metabolite, 6-sulfatox-
ymelatonin (aMTs-6), measured from ﬁrst morning void
urine samples. Urinary aMTs-6 levels correlate well with
circulating melatonin levels in blood, and aMTs-6
concentration in ﬁrst morning void urine accurately
characterises the peak nocturnal melatonin secretion as
well as the total nocturnal melatonin output (accounting
for approximately 70% of total circulating melatonin
from the previous night).
23
Nocturnal melatonin secretion is relatively stable
among individuals; aMTs-6 assessment from a single
morning void urine sample has been found to be highly
reproducible over 3 to 5 years.
19 24 Pilot work in this
study population validates the accuracy of melatonin
assessment from morning void urine, as the timing of
peak melatonin production is not altered (it still occurs
at night) among nurses working this rotating shift
schedule.
25
Prior to commencing their shift, nurses collected their
ﬁrst morning void urine (at 05:00e07:00) and delivered
samples to the KGH core laboratory. Urine samples
were processed, aliquoted and stored at  808C until
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assayed using the Bu ¨hlmann aMTs-6 ELISA (ALPCO,
Salem, New Hampshire, USA) and were adjusted for
creatinine levels (aMTs-6 divided by creatinine concen-
tration, in nanograms per milligram) to account for
variability in the diluteness of urine samples. Creatinine
concentrations were measured from the same urine
samples using the Parameter Creatinine Assay (R&D
Systems, Minneapolis, Minnesota, USA).
All urine samples were analysed in duplicate for
aMTs-6 and creatinine concentrations and an average
concentration and coefﬁcient of variation (CV) were
calculated for each sample. Median CVs for aMTs-6 and
creatinine were 9.1% and 10.0%, respectively. To ensure
data quality, assays for which the standard curve poorly
ﬁt the sample standards (R
2 <0.95) were repeated.
Additionally, samples for which aMTs-6 or creatinine
concentrations were out of range of the assay’s standard
curve were re-analysed using appropriately adjusted
dilutions.
Sex hormone assessment
Concentrations of oestradiol (in picomoles per litre),
oestrone (in picomoles per litre), progesterone (in
nanomoles per litre) and prolactin (in micrograms per
litre) were measured by immunoassay from fasting blood
samples that were taken on the same day and at the same
time (05:00e07:00) as urine samples. Serum levels of
progesterone, oestradiol and prolactin were measured at
the KGH core laboratory, and serum oestrone levels were
measured at the McMaster University Medical Centre.
Blood samples were analysed immediately upon retrieval
at the hospital core laboratory, and blood for oestrone
analysis was processed, aliquoted and frozen prior to
shipment to the McMaster University Medical Centre.
Immunoassay tools were calibrated at each use, and all
samples were analysed with standard controls. Inter-assay
precision (CV) of these analyses were all <20%.
Statistical analysis
Natural logarithms of aMTs-6 and sex hormones were
used for analysis as transformed values more closely
approximated normal distributions. Generalised linear
regression modelling was used to examine relationships
between melatonin and each sex hormone. Relation-
ships were also examined separately by season, as well as
across seasons whereby melatonin levels from the ﬁrst
season were assessed in relation to sex hormone levels
from the second season. For all regression models,
a change-in-estimate selection procedure ($10% change
in the main exposure effect) was used to identify
confounders,
26 while age, body mass index (BMI) and
menstrual cycle stage were included in all ﬁnal models.
Other variables considered potential confounders
a priori included current oral contraceptive use (yes/
no), average physical activity levels (including intensity,
frequency and duration; conceptualised in hours per
week for all intensities and for moderate-vigorous
intensity activity only), alcohol consumption (average
drinks per week), caffeine consumption (average drinks
per week) and smoking status (current, former, never).
All statistical analyses were completed using SAS (V.9.2;
SAS Institute).
RESULTS
Characteristics of the study population are presented in
tables 1 and 2. The majority of nurses had worked night
shifts for at least 5 years. While many women were either
overweight or obese, most women were non-smokers and
did not use oral contraceptives.
No associations were observed between melatonin
(conceptualised as a continuous variable and by tertiles)
and sex hormones (table 3, ﬁgure 1). While an inverse
relationship between melatonin and oestradiol was
suggested in winter (b¼ 0.18, p¼0.04), this result was
not statistically signiﬁcant after accounting for the
confounding inﬂuences of age, BMI, menstrual cycle
stage, oral contraceptive use and recent alcohol
consumption. On investigation of a longer latency
period, melatonin levels in the ﬁrst season were not
associated with oestradiol or oestrone levels in the
second season. No relationship was observed between
melatonin and progesterone or prolactin in crude and
adjusted analyses.
Sensitivity analysis revealed that results were
unchanged with the exclusion of oral contraceptive
users, of nurses who provided blood samples over 1 h
past the prescribed time frame, and when non-trans-
formed variables were used for analyses.
Associations between shift work history (conceptual-
ised as continuous years and <20 vs 20+ years) and sex
hormones are presented in table 4. While statistically
signiﬁcant associations were observed between
Table 1 Baseline characteristics of the study population
(n¼82)
Characteristic N (%)
Personal
Age (years), mean6SD 35.868.2
Body mass index (kg/m
2), mean6SD 27.166.7
Ethnicity
White 79 (96)
Non-white 3 (4)
Lifestyle
Smoking
Smoker 11 (13)
Past-smoker 19 (23)
Never-smoker 52 (63)
Alcohol consumption (drinks per week),
mean6SD
3.463.8
Employment
History of shift work (years), mean6SD 11.068.4
#5 22 (27)
>5e10 28 (34)
>10e15 9 (11)
>15e20 8 (10)
>20 15 (18)
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oestrone and progesterone levels (all ps<0.05), these
results were confounded, particularly by age, and were
not statistically signiﬁcant after confounder adjustment.
Similarly, while geometric means of oestradiol, oestrone
and progesterone were consistently higher among
longer-term shift workers (<20 vs 20+ years), multivar-
iate-adjusted differences were not statistically signiﬁcant.
DISCUSSION
Overall, this study found no evidence for an association
between melatonin, shift work history and sex hormone
levels. While some relationships were observed in crude
analyses, results were not statistically signiﬁcant after
confounder adjustment. Previous studies have reported
statistically signiﬁcant inverse relationships between
melatonin and follicle-stimulating hormone (r ¼ 0.322,
p<0.05), luteinising hormone (r¼ 0.314, p<0.05)
18
and oestradiol (r¼ 0.661, p<0.001)
21 in similar obser-
vational settings, but these results may be attributed to
uncontrolled confounding as the results were not
adjusted for important factors such as age and BMI.
The results of more recent observational studies with
comprehensive confounder assessment are consistent
with our ﬁndings. Two studies investigated relationships
between melatonin and sex hormones in women of the
Nurses’ Health Study cohort.
19 20 Among 80 premeno-
pausal nurses who did not use oral contraceptives,
bivariate associations found between melatonin and
each of bioavailable oestradiol and progesterone were
no longer statistically signiﬁcant after adjustment for age
and BMI.
19 Furthermore, while a longer duration of shift
work (15 years or more) was associated with increased
levels oestradiol (p¼0.03), this result was confounded
and no longer statistically signiﬁcant in multivariate
modelling.
19 The investigation of a larger group of
women (n¼459) in this cohort revealed no association
between melatonin and sex hormone levels.
20 A more
recent study of 206 postmenopausal Japanese women
also found no evidence for a relationship between
melatonin and sex hormones, yet having ‘ever worked
night shifts’ was related to increased oestrone levels
(p<0.01).
22 In sum, the results of our study are
consistent with these recent observational studies,
which show no strong relationships between melatonin
and sex hormones while accounting for confounding
variables.
Despite limited observational evidence, some support
for these relationships has been reported under certain
pathological or pharmacological conditions. Unusually
high melatonin levels have been associated with anov-
ulation, oophorectomy and other abnormal ovarian
conditions,
14 and randomised trials of melatonin
supplementation have shown reductions in oestrogen,
luteinising hormone, follicle-stimulating hormone and
inhibition of ovulation with pharmacologic doses of
melatonin.
15e18 If the proposed relationships exist, it is
possible that under extreme or unnatural conditions
Table 2 Seasonal characteristics of the study population
Characteristic
Summer
(n[68),
N (%)
Winter
(n[65),
N (%)
Reproductive
Menstrual cycle stage
Follicular (days 1e10) 26 (38) 22 (34)
Mid-cycle (days 11e16) 10 (15) 9 (14)
Luteal (day 17+) 28 (41) 32 (49)
Current OC use
Yes 13 (19) 12 (19)
No 53 (78) 51 (79)
Lifestyle
Total physical activity
(all intensities) (hours
per week), mean6SD
4.464.2 4.765.5
Moderate-to-heavy physical
activity* (hours per week),
mean6SD
3.363.7 3.665.4
Caffeinated beverage
consumption (drinks per day),
mean6SD
3.363.3 3.062.7
Percentages may not add due to rounding and/or missing covariate
information (menstrual cycle stage, n¼4; OC use, n¼2).
*Increases the heart rate and breathing rate and may cause
sweating.
OC, oral contraceptive.
Table 3 Multivariate-adjusted associations between creatinine-adjusted 6-sulfatoxymelatonin (in nanograms per milligram)
and sex hormones (log-transformed)
Sex hormone
Analysis
Summer Winter Across Seasons
Parameter estimate
(p value)
Parameter estimate
(p value)
Parameter estimate
(p value)
Oestradiol (pmol/l) 0.005 (0.94)  0.13 (0.11)  0.05 (0.54)
Oestrone (pmol/l) 0.05 (0.36)  0.03 (0.61) 0.05 (0.40)
Progesterone (nmol/l) 0.07 (0.46) 0.14 (0.22)  0.02 (0.86)
Prolactin (mg/l) 0.01 (0.78) 0.003 (0.94)  0.05 (0.40)
Adjusted for age (years), body mass index (kg/m
2), menstrual cycle stage (follicular, mid-cycle, luteal) and OC use (yes/no), recent alcohol
consumption (drinks per day), recent caffeine consumption (drinks per day), smoking status (current/never/former) and total and moderate-to-
heavy recent physical activity levels (hours per week), as appropriate.
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same way, these relationships could be more obvious in
shift workers who experience greater disruptions to their
melatonin secretion, such as permanent night workers
or those with a longer history of shift work. Among our
rotating shift nurses, it is possible that their work
schedule of two 12-h days, followed by two 12-h nights,
followed by 5 days off is not sufﬁciently disruptive to
circadian rhythms to cause such changes in melatonin
and/or sex hormone levels. This could be very good
news to women working this prevalent shift pattern.
The results of this study must be considered in light of
the small sample size. Our study was sufﬁciently powered
(at 80% power and a¼0.05) to detect effect estimates in
the range of 60.2 or greater. Therefore, these results
alone are unable to refute the possibility of small (<0.2)
relationships between melatonin and sex hormones.
This study contributes observational evidence
concerning the relationships between melatonin and sex
hormones as potential intermediates of shift work and
breast cancer, an area with few existing studies that have
had mostly null ﬁndings.
19 20 22 Given the limitations in
Figure 1 Multivariate-adjusted
geometric means of sex
hormones by tertile of creatinine-
adjusted 6-sulfatoxymelatonin
(aMTs-6) (in nanograms per
milligram).
Table 4 Multivariate-adjusted associations between night shift work (continuous years; <20 vs 20+ years) and sex hormones
(log-transformed)
Sex hormone
Continuous shift work (years)
Dichotomous shift work (<20 vs 20+ years), geometric
means (95% CI)
Parameter estimate (p value) <20 years (n[67) 20+ years (n[15) p for Diff
Oestradiol (pmol/l)  0.002 (0.87) 259.4 (198.4e338.9) 269.5 (182.6e397.7) 0.84
Oestrone (pmol/l) 0.005 (0.48) 209.1 (174.3e250.8) 258.6 (197.9e337.9) 0.11
Progesterone (nmol/l)  0.002 (0.86) 7.0 (4.60e10.8) 7.5 (4.28e13.2) 0.79
Prolactin (mg/l) 0.002 (0.79) 16.5 (13.4e20.2) 15.7 (11.8e20.8) 0.71
Adjusted for age (years), body mass index (kg/m
2), menstrual cycle stage (follicular, mid-cycle, luteal) and OC use (yes/no), recent alcohol
consumption (drinks per day), recent caffeine consumption (drinks per day), smoking status (current/never/former) and total and moderate-to-
heavy recent physical activity levels (hours per week), as appropriate.
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which evidence is yet conclusive,
7 the investigation of
potential intermediates may help clarify the plausibility
of this link. Furthermore, an identiﬁcation of the inter-
mediate pathways is crucial to the development of
strategies to minimise the health impacts of this work
schedule. Future studies of ideally larger sample sizes
may consider investigating these relationships among
women working more extreme shift schedules or among
longer-term shift workers, as these groups may be more
likely to experience biological changes that lead to
detectable disruptions of hormone levels.
The results from this study alone cannot rule out these
proposed relationships between melatonin and sex
hormones nor other potential mechanisms to explain
increases in breast cancer incidence among shift
workers. Future studies should investigate other
proposed intermediates of this pathway, including
melatonin’s antioxidant actions and immunomodula-
tory functions.
13 In addition, several alternative pathways
outside the melatonin hypothesis should be considered
including behavioural or lifestyle changes and sleep
disturbances
27 as these changes may also help explain
increases in breast cancer risk among shift workers.
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